Open AccessThe impact of dietary isoflavonoids on malignant brain tumors
Author(s) -
Sehm Tina,
Fan Zheng,
Weiss Ruth,
Schwarz Marc,
Engelhorn Tobias,
Hore Nirjhar,
Doerfler Arnd,
Buchfelder Michael,
Eyüpoglu IIker Y.,
Savaskan Nic E.
Publication year - 2014
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.265
Subject(s) - in vivo , glioma , medicine , neuroprotection , isoflavonoid , pharmacology , biochanin a , brain tumor , ex vivo , cancer research , genistein , mammary tumor , cancer , pathology , daidzein , biology , breast cancer , antioxidant , microbiology and biotechnology , biochemistry , flavonoid
Abstract Poor prognosis and limited therapeutic options render malignant brain tumors one of the most devastating diseases in clinical medicine. Current treatment strategies attempt to expand the therapeutic repertoire through the use of multimodal treatment regimens. It is here that dietary fibers have been recently recognized as a supportive natural therapy in augmenting the body's response to tumor growth. Here, we investigated the impact of isoflavonoids on primary brain tumor cells. First, we treated glioma cell lines and primary astrocytes with various isoflavonoids and phytoestrogens. Cell viability in a dose‐dependent manner was measured for biochanin A ( BCA ), genistein ( GST ), and secoisolariciresinol diglucoside ( SDG ). Dose–response action for the different isoflavonoids showed that BCA is highly effective on glioma cells and nontoxic for normal differentiated brain tissues. We further investigated BCA in ex vivo and in vivo experimentations. Organotypic brain slice cultures were performed and treated with BCA . For in vivo experiments, BCA was intraperitoneal injected in tumor‐implanted Fisher rats. Tumor size and edema were measured and quantified by magnetic resonance imaging ( MRI ) scans. In vascular organotypic glioma brain slice cultures ( VOGIM ) we found that BCA operates antiangiogenic and neuroprotective. In vivo MRI scans demonstrated that administered BCA as a monotherapy was effective in reducing significantly tumor‐induced brain edema and showed a trend for prolonged survival. Our results revealed that dietary isoflavonoids, in particular BCA , execute toxicity toward glioma cells, antiangiogenic, and coevally neuroprotective properties, and therefore augment the range of state‐of‐the‐art multimodal treatment approach.